Diplon, Jeffrey .

HRN: 10-41-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
10/15/2023
10/22/2023
PO
10cc
Q8
Infected Wound
Waiting Final Action 
10/15/2023
MUPIROCIN 2%, 15G (TUBE)
10/15/2023
10/22/2023
TOPICAL
2%
TID
Abrasion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: